Effects Of Prostate Cancer

Featured Article

In a new study, the experimental cancer vaccine Provenge boosted the three-year survival of patients with advanced prostate cancer by 38 percent compared with a placebo. Researchers say the patients in the 512-subject study who received the drug, called Provenge, lived an average 4.1 months longer than those who did not receive the medication. One scientist on the study team said that if the drug becomes commercially available in the United States, he has "no doubt...it will replace...

Read more

More information on "Effects Of Prostate Cancer"

From Our Experts

See more SharePosts »

From Our Sources

More on Prostate »